Company / EPS (Diluted)
Fortress Biotech, Inc. EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$2.69
FY2025
5-year range
-$15.97 / -$0.65
FY2021-FY2025
Trend
+68.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has fluctuated over the past 10 years, ranging from $-15.97 in FY2023 to $-0.56 in FY2016.
Based on SEC 10-K filings.
-2.69 in FY2025.
Improved from $-15.97 to $-2.69 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) increased 68.2% year-over-year.
- Peak eps (diluted) was recorded in FY2016.
- Lowest eps (diluted) in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.69 | +68.2% |
| FY2024 | -$8.47 | +47.0% |
| FY2023 | -$15.97 | -1921.5% |
| FY2022 | -$0.79 | -21.5% |
| FY2021 | -$0.65 | +11.0% |
| FY2020 | -$0.73 | +62.4% |
| FY2019 | -$1.94 | -20.5% |
| FY2018 | -$1.61 | -29.8% |
| FY2017 | -$1.24 | -121.4% |
| FY2016 | -$0.56 | +54.1% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026